Associate Professor of Molecular Medicine and Co-Director of the Humanized Mouse Core Facility at UMass Medical School, Investigator at the JDRF Center of Excellence in New England

Dr. Brehm works with these unique animal models of human immune responses to investigate approaches to downregulate as well as activate the human immune system for treatments of type 1 diabetes (T1D) and cancer. Dr. Brehm's laboratory studies human beta cells from individuals with type 1 diabetes in a real-life setting as they interact with intact T1D immune systems. The ultimate objective is to understand the etiology and pathogenesis of autoimmune T1D, in order to develop new therapies and drugs for personalized medicine.

2019 Brehm Lab Holiday Luncheon